Esketamine Prevents Treatment-Resistant Depression Relapse

Long-term use of esketamine nasal spray in combination with an antidepressant was more effective than an oral antidepressant alone in preventing relapse in patients with treatment-resistant depression, found a trial in JAMA Psychiatry.
Source: JAMA - Category: General Medicine Source Type: research